1.13
price up icon3.67%   0.04
after-market 시간 외 거래: 1.18 0.05 +4.42%
loading
전일 마감가:
$1.09
열려 있는:
$1.1
하루 거래량:
284.26K
Relative Volume:
0.69
시가총액:
$34.24M
수익:
$69.23M
순이익/손실:
$-33.10M
주가수익비율:
-1.00
EPS:
-1.13
순현금흐름:
$-39.26M
1주 성능:
+11.88%
1개월 성능:
+32.96%
6개월 성능:
-70.34%
1년 성능:
-19.29%
1일 변동 폭
Value
$1.05
$1.16
1주일 범위
Value
$0.9807
$1.16
52주 변동 폭
Value
$0.664
$5.0699

Neuronetics Inc Stock (STIM) Company Profile

Name
명칭
Neuronetics Inc
Name
전화
877-600-7555
Name
주소
3222 PHOENIXVILLE PIKE, MALVERN, PA
Name
직원
203
Name
트위터
@tmstherapy
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
STIM's Discussions on Twitter

Neuronetics Inc Stock (STIM) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-10-13 다운그레이드 BTIG Research Buy → Neutral
2021-10-13 다운그레이드 William Blair Outperform → Mkt Perform
2021-01-22 업그레이드 William Blair Mkt Perform → Outperform
2020-02-06 개시 BTIG Research Buy
2018-07-24 개시 Canaccord Genuity Buy

Neuronetics Inc 주식(STIM)의 최신 뉴스

pulisher
05:44 AM

A Piece Of The Puzzle Missing From Neuronetics, Inc.'s (NASDAQ:STIM) 28% Share Price Climb - Simply Wall St

05:44 AM
pulisher
01:51 AM

Head-To-Head Comparison: Neuronetics (NASDAQ:STIM) and Retractable Technologies (NYSE:RVP) - Defense World

01:51 AM
pulisher
Nov 02, 2024

Neuronetics to Unveil Q3 2024 Financial Results - MSN

Nov 02, 2024
pulisher
Nov 01, 2024

Neuronetics extends Madryn registration rights period By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Neuronetics extends Madryn registration rights period - Investing.com India

Nov 01, 2024
pulisher
Oct 29, 2024

Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call - The Manila Times

Oct 29, 2024
pulisher
Oct 24, 2024

Transcranial Magnetic Stimulator Market Projected To Witness Substantial Growth, 2024-2031:Nexstim Plc, - EIN News

Oct 24, 2024
pulisher
Oct 17, 2024

Neuronetics (STU:NRC) Future 3-5Y EPS without NRI Growth Ra - GuruFocus.com

Oct 17, 2024
pulisher
Oct 14, 2024

NeuroStar TMS data presented at AACAP meeting By Investing.com - Investing.com Australia

Oct 14, 2024
pulisher
Oct 14, 2024

NeuroStar TMS data presented at AACAP meeting - Investing.com

Oct 14, 2024
pulisher
Oct 14, 2024

NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression - The Manila Times

Oct 14, 2024
pulisher
Oct 14, 2024

Transcranial Magnetic Stimulator Market will generate new - openPR

Oct 14, 2024
pulisher
Oct 11, 2024

Neuronetics executive sells shares worth over $1,200 By Investing.com - Investing.com South Africa

Oct 11, 2024
pulisher
Oct 11, 2024

Neuronetics executive sells shares worth over $1,200 - Investing.com India

Oct 11, 2024
pulisher
Oct 11, 2024

Neuronetics EVP Stephen Furlong sells shares worth over $1,100 - Investing.com India

Oct 11, 2024
pulisher
Oct 04, 2024

Neuronetics faces potential Nasdaq delisting - Investing.com India

Oct 04, 2024
pulisher
Oct 04, 2024

Neuronetics faces potential Nasdaq delisting By Investing.com - Investing.com UK

Oct 04, 2024
pulisher
Oct 04, 2024

Neuronetics Moves to Acquire Greenbrook in Stock Deal - TipRanks

Oct 04, 2024
pulisher
Oct 04, 2024

Neuronetics Set to Acquire Greenbrook TMS - TipRanks

Oct 04, 2024
pulisher
Oct 04, 2024

Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings - StockTitan

Oct 04, 2024
pulisher
Oct 02, 2024

Neuronetics Outlines Greenbrook Acquisition Prospects and Risks - TipRanks

Oct 02, 2024
pulisher
Oct 02, 2024

SEC Form DEFA14A filed by Neuronetics Inc. - Quantisnow

Oct 02, 2024
pulisher
Oct 02, 2024

Neuronetics Expands TMS Access for Adolescents with Depression - MyChesCo

Oct 02, 2024
pulisher
Oct 02, 2024

Neuronetics GAAP EPS of -$0.27 beats by $0.04, revenue of $17.42M beats by $0.3M - MSN

Oct 02, 2024
pulisher
Sep 30, 2024

STIM stock rated a Mkt perform by William Blair - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

Neuronetics' SWOT analysis: merger, cybersecurity woes shape stock outlook - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

In the Green: Neuronetics Inc (STIM) Closes at 0.75, Up/Down -3.85 from Previous Day - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Neuronetics' SWOT analysis: merger, cybersecurity woes shape stock outlook By Investing.com - Investing.com South Africa

Sep 30, 2024
pulisher
Sep 27, 2024

Neuronetics Inc (STIM) deserves closer scrutiny - US Post News

Sep 27, 2024
pulisher
Sep 26, 2024

Neuronetics Inc [STIM] Shares Fall -6.18 % on Wednesday - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

Neuronetics Inc (STIM) Stock: A Year of Declines and Increases - The InvestChronicle

Sep 26, 2024
pulisher
Sep 26, 2024

Quarterly Snapshot: Quick and Current Ratios for Neuronetics Inc (STIM) - The Dwinnex

Sep 26, 2024
pulisher
Sep 25, 2024

Stoke Therapeutics Inc (STOK) expanding its growth trajectory ahead - SETE News

Sep 25, 2024
pulisher
Sep 25, 2024

Neuronetics announces HCSC expanded access to TMS for adolescents - TipRanks

Sep 25, 2024
pulisher
Sep 25, 2024

In the Green: NeuroSense Therapeutics Ltd (NRSN) Closes at 1.25, Up/Down -3.50 from Previous Day - The Dwinnex

Sep 25, 2024
pulisher
Sep 25, 2024

Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents - Yahoo Finance

Sep 25, 2024
pulisher
Sep 25, 2024

NeuroMetrix (NASDAQ:NURO) Research Coverage Started at StockNews.com - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

NeuroSense Regains Compliance with NASDAQ Minimum Bid Price Rule - PR Newswire

Sep 24, 2024
pulisher
Sep 24, 2024

How did Stoke Therapeutics Inc (STOK) fare last session? - US Post News

Sep 24, 2024
pulisher
Sep 24, 2024

Logos Global Management LP Invests $14.19 Million in Stoke Therapeutics, Inc. (NASDAQ:STOK) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Recent Insider Activity Could Benefit Stoke Therapeutics Inc (STOK) - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Stoke Therapeutics (NASDAQ:STOK) Stock Price Down 4.7% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

STIM Stock Likely to Gain From Updated TMS Coverage - Zacks Investment Research

Sep 23, 2024
pulisher
Sep 22, 2024

First Eagle Investment Management LLC Purchases 260,000 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Neuronetics Expands TMS Coverage, Enhancing Access for MDD Treatment - MyChesCo

Sep 21, 2024
pulisher
Sep 19, 2024

Neuronetics Enhances NeuroStar Therapy with New Features - MSN

Sep 19, 2024
pulisher
Sep 19, 2024

Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults - StockTitan

Sep 19, 2024
pulisher
Sep 18, 2024

Acadian Asset Management LLC Purchases 62,628 Shares of Neuronetics, Inc. (NASDAQ:STIM) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Greenbrook TMS announces acquisition by Neuronetics - Investing.com Canada

Sep 18, 2024
pulisher
Sep 17, 2024

STIM’s Stock Swings: Riding the 2023 Wave of Ups and Downs - The InvestChronicle

Sep 17, 2024

Neuronetics Inc (STIM) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Neuronetics Inc 주식 (STIM) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
Oct 08 '24
Sale
0.82
1,541
1,264
402,792
$226.42
price up icon 3.48%
diagnostics_research LH
$229.11
price up icon 0.85%
diagnostics_research WAT
$387.17
price down icon 0.04%
$154.96
price up icon 0.96%
diagnostics_research MTD
$1,385.79
price up icon 1.60%
$415.98
price up icon 0.35%
자본화:     |  볼륨(24시간):